board of directors
Harald Nordal (1958) is a co-founder of the Company and has served at the board of directors since the founding of the company. He has served as chairman from 2011 to January 2015 and from December 2015. He has extensive experience from national and international senior board and executive management positions in industry and biosciences and currently serves as CEO of Life Capitol AS. He sits on the board of directors of Regenics AS and Hyperthermics AS. He holds a MSc in Civil Engineering from the Norwegian University of Science and Technology (NTNU) and a MBA in Project Management from the SKEMA Business School, France.
Chairman and co-founder since 2011
Jostein Christian Dalland (1969) has served as an independent board member of the Company since 2020. He currently holds the position of Executive Vice President and part of the executive management group at Sbanken . Prior to joining the board of directors of the Company, Mr Dalland has worked as CEO of SpinChip Diagnostics, Executive Vice President and part of the executive management group at Storebrand ASA, Chairman of BIOTEK2021 at the Norwegian Research Council, CEO of Inven2, and Executive Vice President of Marketing and Sales at Aker Biomarine ASA after Aker acquisition of Natural ASA where he was the CEO. He has an MBA (siviløkonom) and a Master of Technology Management from NHH/NTNU.
Member of the board since 2020
Per Magne Eggesbø (1963) has served as a board member of the Company since 2016. He currently holds the position as CEO of Eros AS and Eggesbø Eiendom AS as well as several other family owned companies. Before he joined the family business in 1998 he worked more than 8 years in Nordea Bank as a Senior Vice President within the Fisheries Divison, working both out of Oslo, Seattle and Aalesund. Mr. Eggesbø holds a Master of Science in Business from the Norwegian Business School.
Member of the board since 2016
Asbjørn Solevågseide (1960) has served as a board member of the Company since 2019. Mr Solevågseide has worked in various senior management positions within fish handling process equipment industries since 1986. He funded Seatech AS in 1997 that merged with Optimar in 2000. In Optimar Mr Solevågseide held the position of CEO and largest owner until Optimar was sold to Franz Haniel &Cie. Gmbh in 2019. He currently works as an investor at Ajea Invest AS and serves in several board positions including as board chairman of Pir Invest IV.
Member of the board since 2019
Tore Andreas Frøysa Tønseth (1980) has served as a board member of the Company since January 2021. He currently works as an Investment Director at Ronja Capital AS. Prior to joining the Company, Mr Tønseth has worked as an Equity Analyst at SpareBank 1 Markets and Pareto Securities. Mr Tønseth holds a Master's Degree in Finance from the Norwegian School of Economics.
Member of the board since 2020
Jan Endre Vartdal (1971) has served as a board member of the Company since 2015. He is known for his business acumen and passion for developing companies through building teams and culture. In 1997, together with his two siblings, Jan Endre Vartdal took over the family company Vartdal Plastindustri AS. Since 2008 Jan Endre Vartdal has been CEO of the company, which under his leadership has grown from a single factory company with 70 employees to a group employing more than 250 people running five factories located in all parts of Norway under the group name Vartdal Plast and revenues of 800 MNOK in 2019. Jan Endre Vartdal and Vartdal Plast have taken on the role as leaders of the green shift within the EPS industry and their efforts have received a lot of praise both in Norway and abroad. Under Jan Endre Vartdal’s leadership Vartdal Plast has grown to become one of Scandinavia’s market leaders within the EPS industry. Mr. Vartdal currently sits on the board of the Confederation of Norwegian Enterprise Møre og Romsdal (NHO). In addition to this, he is involved in the development of several companies and projects as investor and board director. Mr. Vartdal has his educational background from Norwegian Business School and MR Technical College.
Member of the board since 2015
Hu Cao will be a member of the Board of Directors of the Company effective from the first day of trading on Euronext Growth Oslo. Hu Cao has served since 2012 as a global partner in Kotler Marketing Group (KMG) and CEO of the greater China region. Under his leadership and joint effort with nearly 100 marketing professionals in the KMG team, KMG China has been elected by "China Manager" magazine as the No.1 strategic marketing consulting firm in China. From 2001-2011, Mr. Cao worked for KMG China as a business analyst, consultant, project manager and division director. From 1997-2000 he worked as a production manager in the Cosmetics Division of Henkel Group (China). Mr. Cao has over 20 years’ management and consulting experience in strategic marketing, brand strategy, B2B marketing, digital marketing transformation, channel management, marketing and sales organization design and optimization in 11 different industries. Recent clients in global marketing strategy and marketing management include: Alibaba International, Baidu, TCL Group, Baosteel Group, AVIC International, Vanke Group, Guangzhou Pharmaceutical Group, Taiji Pharmaceutical Group, Pfizer China, Yangzi River Pharmaceutical Group, Yiling Pharmaceutical Group. Tsinghua Yuanxing Bioscience, Futian Automobile, Yutong Bus, Sany Group, China Storage, Bank of China, P&W, General Motors China, Sinochem Group, Shield Group, China Merchants Group, China Textile Group, Skyworth Group, Ping An Property & Casualty, Vanke Real Estate, China Resources Snow Beer (China) Co., Ltd. Mr. Cao currently serves as Chairman of Kotler Medical Park (Song Shan Lake) China and obtained his bachelor degree in biochemistry from Wuhan University.